153 results on '"Dobrzanski, Pawel"'
Search Results
2. Capacity of Industrial Structure: The Case of Eastern and Central Europe
3. The impact of load on the wheel rolling radius and slip in a small mobile platform
4. Conditions for Development of Japanese Economy
5. Innovation Catching Up for Developing Countries
6. Left-behind places in central and eastern Europe—labour productivity aspect.
7. Assessment of Government Activity in the Economy: USA–Germany–Japan–China
8. Spending on Innovation as a Factor of Competitiveness of Market Economies
9. Supplementary Figure 21 from Arginase 1/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy
10. Supplementary Figure 18 from Arginase 1/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy
11. Data from Arginase 1/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy
12. Supplementary Tables 1-11 from Arginase 1/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy
13. Supplementary Materials and Methods from Arginase 1/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy
14. Supplementary Figures 2 - 14 from Arginase 1/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy
15. Data from CEP-32496: A Novel Orally Active BRAFV600E Inhibitor with Selective Cellular and In Vivo Antitumor Activity
16. Supplementary Data 1 from CEP-32496: A Novel Orally Active BRAFV600E Inhibitor with Selective Cellular and In Vivo Antitumor Activity
17. Arginase 1/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy
18. Innovation Catching Up for Developing Countries
19. Conditions for Development of Japanese Economy
20. Automatic Correction of an Automated Guided Vehicle’s Course Using Measurements from a Laser Rangefinder
21. Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoidosis
22. Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoidosis
23. Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoidosis
24. The Automotive Industry in The European Union, 2014- 21
25. Efficiency of Environmental Protection Expenditures in EU Countries
26. Structural and Productivity Changes in the European Countries During COVID-19 Pandemic
27. The Impact of the Pandemic on Vehicle Traffic and Roadside Environmental Pollution: Rzeszow City as a Case Study
28. The Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) -Genesis and Challenges of The Trans-Pacific Mega-Regionalism in Trade
29. Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders
30. Economics of Digital Transformation
31. D Expenditures in ASEAN Countries
32. The many faces of Janus kinase
33. Measurement of Wheel Radius in an Automated Guided Vehicle
34. Therapeutic efficacy of the chitotriosidase inhibitors in STAM model of non-alcoholic steatohepatitis
35. The efficiency of spending on R&D in Latin America region
36. The Efficiency of R&D Expenditures in ASEAN Countries
37. CEP-1347/KT-7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Aβ-induced cortical neuron apoptosis
38. Rzeszow as a City Taking Steps Towards Developing Sustainable Public Transport
39. Productivity performance of the Czech Republic - Shift-Share Analysis
40. Toward Innovation-Driven Competitiveness Across African Countries: An Analysis of Efficiency of R&D Expenditures.
41. CHIT1 is a novel therapeutic target in idiopathic pulmonary fibrosis (IPF): anti-fibrotic efficacy of OATD-01, a potent and selective chitinase inhibitor in the mouse model of pulmonary fibrosis
42. Late Breaking Abstract - Phase 1, first-in-human study of OATD-01, a dual chitinase inhibitor for the treatment of respiratory diseases
43. Abstract B003: Development of OAT-1746, a novel arginase 1 and 2 inhibitor for cancer immunotherapy
44. STRUCTURAL CHANGE PATH AND ECONOMIC GROWTH PERFORMANCE OF POLISH ECONOMY.
45. INCOME DISPROPORTION BETWEEN CENTRAL AND EASTERN EUROPE REGIONS.
46. COMPETITIVENESS OF EUROPEAN UNION'S AUTOMOTIVE INDUSTRY.
47. INCOME INEQUALITY IN EU COUNTRIES.
48. Structural and productivity changes of Central and Eastern Europe.
49. Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK)
50. Promoter inactivation or inhibition by sequence-specific methylation and mechanisms of reactivation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.